^
Association details:
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
New
Title:

The distribution of BRAF gene fusions in solid tumors and response to targeted therapy

Excerpt:
A malignant spindle cell tumor of the chest wall treated as a soft tissue sarcoma featured a KIAA1549‐BRAF fusion (Fig. ​(Fig.5)5) and responded to treatment with the pan‐kinase inhibitor sorafenib in combination with bevacizumab and temsirolimus.
DOI:
10.1002/ijc.29825